Employers & Consultants
As Seen In: Insurance Business
PBM disclosure rules still leave benefits brokers with unanswered questions
The pharmacy market has changed. Has the way we evaluate it? More transparency into pharmacy benefits is a…
As Seen In: BenefitsPRO
The future of pharmacy benefits isn’t transparency. It’s access.
For years, pharmacy benefit reform has centered on transparency. Employers have pushed for greater visibility into drug pricing,…
As Seen In: Drug Topics
Understanding the restructure of US pharmacy benefits
For years, much of the conversation about pharmacy benefits has focused on reform: greater transparency, clearer economics and…
As Seen In: Managed Healthcare Executive
PBMI Innovators: Raechele McMahan, SVP, Prescryptive
In the August 2026 issue of Managed Healthcare Executive, the publication featured six PBMI Innovators, including Raechele McMahan,…
3 ways the modern prescription experience is starting to look more like modern commerce
New direct-to-patient prescription models are emerging as consumers demand the same convenience, transparency, and digital control they experience…
Prescryptive Helps Power LillyDirect®, Supporting Direct-to-Patient Access
Redmond, WA – May 6, 2026 – Prescryptive Health today announced it serves as a technology platform helping to…
As Seen In: Authority Magazine
Chief Executive Officer Chris Blackley on the healthcare leadership operating system
“A huge challenge for healthcare leaders is that they are being asked to sustain high performance inside systems…
As Seen In: SHRM
GLP-1 pills are here: What does it mean for employers?
Will GLP-1 pills change how employers approach coverage? It’s an important question, but the answer isn't so straightforward.
As Seen In: EBN
As Ozempic costs fall, demand for weight-loss drugs is set to surge
On the surface, lower GLP-1 prices should make these therapies easier to manage. But as Rae McMahan, SVP…
Direct access isn’t a program – it’s market design
Welcome to a direct access marketplace, where incentives are aligned by design so access becomes the default outcome.
As Seen In: Reuters
Data shows US advertising spend increasing for pharma manufacturers
Even with increased availability, access to GLP-1 therapies can be challenging for employers and healthcare consumers due to…
As Seen In: HIT Consultant
Prescryptive and Ilant Health Partner to Deliver Transparent Pricing and Clinical Excellence
Access is the new standard – and with partners like Ilant Health, Prescryptive is delivering it. Our collaboration…